Deczone-S 500mg/250mg Injection
Marketer
Daksh Pharma Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Deczone-S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise treatment efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; intensified symptoms necessitate immediate medical consultation. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor about all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While usually non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and hydration are vital for optimal recovery. Follow-up laboratory tests may be required to monitor therapeutic response.
Uses of Deczone-S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Deczone-S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Deczone-S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Deczone-S 500mg/250mg Injection:
Administering this medication requires a healthcare professional; please do not attempt self-medication.
How Deczone-S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Deczone-S 500mg/250mg Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions associated with the concurrent use of Deczone-S 500mg/250mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication, Deczone-S 500mg/250mg, is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Deczone-S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Deczone-S 500mg/250mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Deczone-S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Deczone-S 500mg/250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Deczone-S 500mg/250mg Injection are unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Deczone-S 500mg/250mg Injection :
Should you forget a scheduled Deczone-S 500mg/250mg Injection, seek medical advice.
Facts to Know About Deczone-S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently